Biomarkers of eosinophilic inflammation in asthma.

Abstract

Eosinophils are mediators of allergic inflammation and are implicated in the pathogenesis of numerous conditions including asthma, parasitic infections, neoplasms, hyper-eosinophilic syndromes, vasculitic disorders, and organ-specific conditions. Assessing eosinophilic inflammation is therefore important in establishing a diagnosis, in monitoring and assessing response to treatment, and in testing novel therapeutics. Clinical markers of atopy and eosinophilic inflammation include indirect tests such as lung function, exhaled breath condensate analysis, fractional exhaled nitric oxide, serum immunoglobulin E levels and serum periostin. Direct measures, which quantify but do not anatomically localise inflammation include blood eosinophil counts, serum or plasma eosinophil cationic protein and sputum eosinophil levels. Cytology from bronchoalveolar lavage and histology from endobronchial and transbronchial biopsies are better at localising inflammation but are more invasive. Novel approaches using radiolabelled eosinophils with single-photon emission computed tomography, offer the prospect of non-invasive methods to localise eosinophilic inflammation.

• Authors: Chrystalla Loutsios, Neda Farahi, Linsey Porter, Laurence S C Lok, A Michael Peters, Alison M Condliffe, Edwin R Chilvers
• Journal: Expert review of respiratory medicine (Expert Rev Respir Med) Vol. 8 Issue 2 Pg. 143-50 (Apr 2014) ISSN: 1747-6356 [Electronic] England
• PMID: 24460178 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Biomarkers
• Inflammation Mediators

Topics

• Asthma (blood, diagnosis, immunology, pathology)
• Biomarkers (analysis)
• Biopsy
• Bronchoalveolar Lavage
• Bronchoalveolar Lavage Fluid (immunology)
• Eosinophils (immunology, pathology)
• Humans
• Inflammation Mediators (analysis)
• Predictive Value of Tests
• Prognosis
• Pulmonary Eosinophilia (blood, diagnosis, immunology, pathology)